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ScienceDirectThe study of immunity to helminth infection has been central to
understanding the function of type 2 cytokines and their
targets. Although type 2 cytokines are considered anti-
inflammatory and promote tissue repair, they also contribute to
allergy and fibrosis. Here, we utilise data from helminth
infection models, to illustrate that IL-17 and neutrophils,
typically associated with pro-inflammatory responses, are
intimately linked with type 2 immunity. Neutrophils work with
IL-4Ra-activated macrophages to control incoming larvae but
this comes at a cost of enhanced tissue damage. Chitinase like
proteins (CLPs) bridge these diverse outcomes, inducing both
protective IL-17 and reparative Th2 responses. Dysregulation
of CLPs, IL-17 and neutrophils likely contribute to disease
severity and pathology associated with type 2 immunity.
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Introduction
It has long been appreciated that type 2 immunity is
critical for the control of helminth infections, while also
contributing to allergic pathology [1]. More recently, type
2 cytokines have been shown to be unexpected but
important players in healthy host metabolism, wound
repair and even regulation of body temperature [2].
Indeed, the evolutionary association of type 2 immunity
with helminth infection may in part be related to the
damage these parasites cause [3] as well as the nutritional
demands they place on the host [4]. Adaptive Th2
responses thus likely evolved not only to reduce parasite
burden, but foster repair and maintain physiological bal-
ance. Moreover, the need to rapidly return the host towww.sciencedirect.com homeostasis [3,5] would apply not only to helminth
infection but physical insults in general [6,7].
Understanding how type 2 cytokines regulate such diverse
processes as helminth killing, tissue repair, host energy
balance and thermoregulation is a serious challenge. How-
ever, studying helminth infections will be a major route to
enlightenment. From plants to fish, and from domesticated
mammals to wild mammal populations, helminth burden is
directly and negatively correlated with host fitness [8–11].
Metazoan parasites are therefore likely to have been a
central evolutionary force in the shaping of type 2 immune
pathways. In a telling example from the unmanaged pop-
ulation of Soay sheep on St Kilda, parasitic nematodes
especially in combination with malnutrition and severe
weather, are the major determinants of failure to survive
[8,12,13,14]. Thus, regulating energy metabolism and
body temperature may be crucial to reproductive success
in the face of helminth infection, providing a possible
explanation for the association of type 2 immunity with
these seemingly unrelated processes.
The well-documented downregulation of type 1 immunity
by type 2 cytokines can also be understood in the context of
adaptation to helminth infection. Faced with large tissue
migrating parasites, suppression of a pro-inflammatory type
1 response, would prevent collateral damage to the host as
well as facilitate wound healing [3]. More unexpectedly,
there is emerging evidence of a positive link between type
2 immunity and IL-17, that may explain some of the more
severe pathological consequences of type 2 immunity such
as fibrosis and asthma [15]. In this review, we will discuss
what has been learned from helminth infection models
about the central role of macrophages in type 2 immunity
and what we are now learning about their critical interac-
tions with neutrophils and IL-17.
Macrophages — a paradigm for type
2 immunity
Type 2 immunity is a highly complex multi-cellular,
multi-factorial system characterized by the cytokines
IL-4, 5, 9, 10 and 13 [1]. The IL-4Ralpha chain, a
component of both the IL-4 and IL-13 receptor, is fun-
damental to type 2 immune function [1]. Expression and
engagement of IL-4Ra on immune effector cells (e.g.
macrophages, B cells) and tissue cells (e.g. smooth mus-
cle, epithelial cells) dictates the outcome of a type 2 im-
mune response. Loss of the IL-4Ra will render
experimental animals more susceptible to infection with
nematodes highlighting the importance of typeCurrent Opinion in Immunology 2015, 34:99–106
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The impact of type 2 cytokines is not limited to any
particular cell, tissue or body system but a central player is
the macrophage, present in virtually all tissues of the body
and strongly responsive to IL-4 and IL-13. IL-4Ra acti-
vated macrophages (Mw(IL-4)) have a highly distinctive
expression profile in vivo, characterized in mice by the
production of the chitinase-like protein Ym1, RELMa
and arginase among others [17,19]. Unravelling macro-
phage function in response to IL-4Ra signalling has
opened doors to the enormous spectrum of type 2 immune
effector functions [17].
Although the evidence was slow to emerge, Mw(IL-4)
have a central role in host resistance to nematode infec-
tion. A seminal study by Anthony et al. demonstrated that
clodronate-mediated monocyte depletion prevents worm
expulsion from the intestine during secondary infection
with the gastrointestinal nematode, Heligmosomoides poly-
gyrus [20]. More recently Fc receptor engagement has
been shown to play an essential role in activating macro-
phages to immobilise migrating H. polygyrus larvae [21].
Larval trapping in vitro did not require the IL-4Ra, but it
may be required in vivo to generate sufficient macrophage
numbers [21,22]. Critically, the effects of macrophages on
helminth control are not always direct. For example,
macrophage depletion alters intestinal smooth muscle
function that is needed to expel the hookworm-related
nematode, Nippostrongylus brasiliensis, from the small in-
testine [23]. All three of these studies implicated arginase
as an important anti-parasite mediator although the IL-
4Ra was not always required for its expression [21].
Beyond their roles in host resistance, it is evident that
macrophages, like type 2 immunity itself, are needed for
host tolerance to the damaging effects of infection. For
example, many of the type 2 immune pathways involved
in host resistance, such as arginine metabolism, are also
directly involved in tissue repair [reviewed in [24]].
Indeed, the key markers of Mw(IL-4) in vivo, Ym1,
RELMa and arginase are all associated with injury in-
dependently of exposure to helminth infection [25]. The
best evidence that macrophages contribute to repair
comes from a study in which Mw(IL-4) are needed to
limit excessive damage caused by migration of N. brasi-
liensis larvae through the lung en route to the intestine
[26]. The well-documented  anti-inflammatory proper-
ties of Mw(IL-4) [24] are key to their wound repair
functions, as suppression  of classical inflammation is
needed for repair to progress [27].
Finally, one of the most exciting areas in type 2 immunity
research is energy metabolism. Pro-inflammatory macro-
phages utilise aerobic glycolysis for energy, while the stat-
6 dependent transcription programme of Mw(IL-4) relies
on fatty acid oxidation [28]. The divergence in metabolic
programme is not only evident within macrophages, butCurrent Opinion in Immunology 2015, 34:99–106 type 2 cytokines can alter the whole body metabolism
with major implications for conditions such as obesity and
diabetes prevalent in western, helminth-free societies
[29]. In the context of resistance to helminth infection,
fatty acid oxidation has been shown to be important for
IL-4 mediated protection against H. polygyrus [30]. How-
ever, the consequences of a type 2 mediated metabolic
shift for helminth infection remains to be explored more
broadly and may relate to the ability of the host to cope
with infection when nutritionally compromised.
Neutrophils and type 2 cytokines
As knowledge of macrophage activation by type 2 cyto-
kines grows, there is increasing evidence that these cells
rarely act alone to mediate their effector functions. Not
surprisingly, eosinophils are essential partners in the
performance of type 2 functions [31–33]. More unexpect-
edly, a number of studies have revealed that macrophages
can also act in partnership with neutrophils, to contain or
kill nematode parasites. Neutrophils have been described
in the macrophage-rich nodules that form around the
adult filarial nematode Litomosoides sigmodontis in the
pleural cavity [34] and the cysts containing H. polygyrus
larvae in the intestine [20,35]. In L. sigmodontis infection,
blockade of the type 2 cytokine IL-5 prevented neutro-
phil accumulation, nodule formation and led to parasite
survival [34]. More recently, neutrophils and macro-
phages have been shown to collaborate in the immobili-
zation and killing of larval stages of the parasitic
nematode Strongyloides stercoralis [36]. This joint venture
between neutrophils and macrophages is complement
dependent [36] and can also involve neutrophil extra-
cellular traps (NETs) [37]. The requirement for comple-
ment is interesting in light of evidence that Mw(IL-4) at
that site of nematode infection make abundant C3 [38].
Considering the strong link between neutrophils and type
1 pro-inflammatory processes that are typically sup-
pressed by IL-4 [39,40], the association of neutrophils
with type 2 immunity has been somewhat surprising.
This likely reveals our ignorance of the full capacity of
neutrophil function beyond their well-known roles in
inflammatory tissue damage and protection against bac-
terial infection [41]. The idea that neutrophils have
distinct subsets, akin to macrophage activation pathways,
was presented by Tsuda et al. in 2004 [42] and has been
discussed in the context of tumor-associated neutrophils
[43]. These observations took a major step forward with
the recent finding that neutrophils adopt an ‘N2’ pheno-
type during N. brasiliensis infection in the lung, demon-
strated by the upregulation of IL-13, IL-33, Igf1, Retnla
(RELMa) and Chi3l3 (Ym1) [44]. The N2 neutrophils
were induced during primary N. brasiliensis infection and
then ‘instructed’ macrophages during secondary infection
to mediate parasite damage and clearance. This coopera-
tion is dependent on IL-4Ra expression by the macro-
phage [44]. Whether IL-4Ra expression on neutrophils iswww.sciencedirect.com
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as TLR ligands can upregulate IL-4Ra on neutrophils [45]
and these signals may combine to generate the N2 phe-
notype described by Chen et al. [44]. The discovery of N2
neutrophils during helminth infection is likely the tip of the
iceberg for the function of neutrophils in type 2 immunity.
We recently showed that neutrophils form organized
swarms around larvae in the early stages of N. brasiliensis
infection in the lung and in the absence of neutrophils
more parasites survived to enter the intestine [46].
However, the neutrophilia associated with migrating lar-
vae comes at a cost. Chen et al. elegantly demonstrated
that neutrophils are responsible for enhanced lung dam-
age caused by larval migration [26], which we subse-
quently confirmed [46]. Therefore, although
neutrophils act in concert with macrophages to contain
nematode infection, neutrophils can also enhance the
more severe consequences of type 2-mediated pathology
as discussed below in relationship to IL-17.
IL-17 and type 2 cytokines
IL-17, through the induction of cytokines and chemo-
kines, is a major driving force for the recruitment and
activation of neutrophils [47]. Therefore, the contribution
of neutrophils to nematode killing and enhanced lung
damage during larval migration pointed towards the in-
volvement of IL-17, and indeed this appears to be the
case. Chen et al. demonstrated that neutrophil recruit-
ment and the consequent enhanced lung damage was
reduced in IL-17ra deficient mice infected with N. bra-
siliensis [26]. We subsequently showed in the same lung
migration model that IL-17A deficient animals were
protected from the peak of tissue damage [46]. In
addition, IL-17 is associated with more severe pathology
in both murine and human schistosomiasis [48,49] and
human onchocerchiasis [50] These data are consistent
with the proposal that IL-17 pushes the type 2 response
into a more pathological state [51]. The ability of IL-17 to
exacerbate type 2 pathology has recently become a cen-
tral focus of asthma research [reviewed in [15]].
The relationship between IL-17 and type 2 immunity is
highly complex (Figure 1). Mice deficient in IL-17A fail
to induce IL-13 when infected with N. brasiliensis [46].
This is consistent with previous reports in allergy models
in which type 2 cytokines are reduced in IL-17 deficient
mice relative to wildtype animals [52,53]. This suggests
paradoxically that IL-17 promotes type 2 responses, sup-
ported by reports in which neutrophils contribute to the
subsequent type 2 response during N. brasiliensis infection
[44,54]. However, as discussed below, in this same nem-
atode model Th2 cytokines suppress IL-17A in the lung
[26], as also reported by others [55,56]. Thus, it appears
that larval entry into the lung promotes an early IL-17/
neutrophil response that is needed to generate the subse-
quent type 2 response. The type 2 response will mediatewww.sciencedirect.com repair of neutrophil induced damage, while shutting down
the initial IL-17 response.
The evidence that IL-17 promotes type 2 responses is
strong, but the reverse may also be true. The eggs
deposited by schistosome parasites are potent inducers
of type 2 cytokines [57] but severe hepatic granulomatous
pathology in response to the eggs is due to a pathogenic
Th17 response, which is largely dependent on the ex-
pression of CD209a by dendritic cells [58]. The expres-
sion of CD209a is highly upregulated in response to IL-4
or IL-13 [38,59,60], suggesting the potential for a ampli-
fication of IL-17 responses by type 2 cytokines. This is
consistent with data in which instillation of IL-13 induces
IL-17 producing CD4+ and gd T cells [61]. These
observations that type 2 cytokines promote IL-17 pro-
duction contrasts sharply with the previously described
ability of type 2 cytokines to negatively regulate the IL-
17 response [26,55,56] but this may reflect an important
negative feedback loop.
The intricate interplay between IL-17/neutrophils and
the type 2 response will play out differently depending on
dose, timing and the specific cell types involved (e.g.
innate lymphoid cells including gd cells vs adaptive
Th17/Th2) [61]. Nonetheless, a general story in which
early neutrophil-IL-17 activation initiates events that
promote a subsequent type 2 response, which in turn
suppresses excessive neutrophilia is likely to be common.
When the type 2 response fails to fully suppress the IL-17
response, or indeed further promotes it, excessive type
2 pathology may be the result. Understanding what
regulates these IL-17 — IL-4/13 feedback loops will pro-
vide invaluable insight into situations in which IL-17
exacerbates type 2 pathology.
Chitinase-like proteins — a bridge between
IL-17 and type 2 responses
An important link between type 2 immunity and IL-17
may lie with the glycoside hydrolase family 18 that
include chitinases and chitinase-like proteins (CLPs).
This protein family is essentially ubiquitous in type 2-
dominated pathophysiological conditions with evi-
dence for roles in helminth infection [62,63], allergy
[64,65], cancer, and wound healing [25,66]. Chitinases
degrade chitin, a sugar polymer found abundantly in
nature but not in mammals. However, gene duplication
events and loss-of-function mutations have resulted in
the CLPs, which cannot degrade chitin. These proteins
appear to be undergoing very rapid evolution [67]
and thus no two mammalian species express the same
set of these proteins. Mice have three CLPs (Ym1, Ym2
and BRP-39), while humans have two (YKL-39 and
YKL-40). Ym1 is the most abundant Mw(IL-4) protein
in many helminth infection models [68], and all the
murine CLPs and YKL-40 are induced via IL-4Ra
signalling [69].Current Opinion in Immunology 2015, 34:99–106
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A model for IL-17 interactions with type 2 cytokines. In response to injured epithelium IL-17 is produced by gd T cells and by Th17 cells, leading
to the accumulation of neutrophils which promote lung injury. IL-17 also enhances the production of IL-4 and IL-13 from innate lymphoid cells and
Th2 cells, which can act in a negative feedback loop shutting down further IL-17 production and neutrophilia. Conversely, type 2 cytokines may
amplify Th17 responses in a manner dependent on CD209a expression on DCs, thus exacerbating pathology. In some circumstances neutrophils
can switch to an N2 phenotype, contributing to the pool of IL-13, which in addition to IL-4, promotes activation of macrophages limiting further
injury and promoting repair.Despite the strong association with type 2 immunity, we
recently made the unexpected discovery that the murine
CLPs induce IL-1 leading to the expansion of IL-17
producing gd T cells [46]. In the context of N. brasiliensis
larval migration, Ym1 induced IL-17, which was responsible
for increased recruitment of neutrophils to the lung [46].
These data strongly suggest, but have not yet proven, that
CLPs activate the inflammasome and potentially act to alert
the host to danger [70]. The abundance of secreted CLPs in
both the tissue and serum, does not lend itself to the idea
that CLPs have a highly specific receptor. Indeed, yeast two
hybrid screening and binding assays have revealed multiple
targets of CLPs, although specific binding partners, 12/15
lipoxygenase and IL-13Ra2, were the focus of these manu-
scripts [71,72]. CLPs bind extracellular matrix components
(ECM) and cell-surface glycosaminoglycans [73], which
themselves interact with many immune mediators. The
impact of CLPs may thus be indirect via interaction or
competition for ligands with their carbohydrate partners. In
this regard, CLPs may be like other nonstructural proteins
expressed in the ECM, such as Osteopontins and various
galectins, which are upregulated upon injury and have been
described as danger signals [74]. In addition, the propensity
of Ym1 to form crystals [75] may be particularly relevant, as
crystals are known inflammasome activators [76].
CLPs may prove to be an important bridge between the
type 2 immune and IL-17/neutrophil pathways. In this
scenario, innate sources of CLPs, perhaps acting asCurrent Opinion in Immunology 2015, 34:99–106 danger-associated molecular patterns, activate IL-1 re-
lease leading to IL-17 production by innate gd T cells,
which in turn drives a type 2 response needed for repair.
Subsequently type 2 cytokines induce even more CLP
expression, which likely further contribute to repair
(Figure 2). Additionally, Ym1 can promote Th2 differenti-
ation [77] as well as suppress IFNg [46,78] further
promoting type 2 immunity. An ability of CLPs to activate
the inflammasome might relate to earlier studies implicat-
ing low level triggering of the inflammasome with priming
of the Th2 response [79]. The N. brasiliensis model suggests
that once the full adaptive Th2 response is enabled it
effectively suppresses the IL-17 response [26]. Of note,
van Dyken et al. recently demonstrated that chitin induces
both IL-13-producing ILCs and IL-17-producing gd T
cells, with the ILCs responsible for suppression of the
IL-17 response [55]. The relationship of CLPs to these
effects of chitin exposure has not been explored. A key
question that remains is whether CLPs can still promote
IL-17 and neutrophils in the context of a memory Th2
response. This seems likely, as mice sensitized to allergen
and then treated with anti-Ym1 at the time of challenge
have suppressed lung neutrophilia [46] suggesting that
the pro IL-17 functions of CLPs may be relevant beyond
their roles in the first few hours and days. Further, it would
suggest that CLPs are key players in the IL-17 enhance-
ment of type 2 pathology, consistent with YKL-40, one of
the two human CLPs, as a marker of disease severity in a
range of conditions [80–83].www.sciencedirect.com
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A model for CLP regulation of type 2 cytokines and IL-17. Injury or insult to the epithelium, whether by a multicellular parasite, chitin containing
pathogen, or allergens, elicits danger signals resulting in the production of chitinase-like proteins (CLPs). CLPs induce IL-1 release leading to
increased secretion of IL-17 and downstream neutrophil recruitment. Along with type 2 promoting cytokine such as TSLP, IL-33, and IL-25 [55],
CLPs also promote type 2 immunity via DCs and suppression of IFN-g. IL-17 and type 2 cytokines can regulate one another as illustrated in
Figure 1. The ensuing type 2 response activates the IL-4Ra on macrophages which in turn produce further CLPs (i.e. Ym-1). Mw(IL-4) act in
concert with neutrophils to kill invading worms in a complement, Arg-1 and NET dependent manner, while also repairing the injury caused by the
parasite or the increased neutrophiliaConcluding remarks
Studies of the host response to helminth infection have
started to elucidate the contribution of neutrophils and
IL-17 to type 2 regulated processes. Beyond their role in
helminth killing and wound repair, it will be imperative to
ask whether neutrophils and IL-17 also contribute to
other type 2 cytokine regulated mechanisms (e.g. host
metabolism). The relationship of type 2 cytokines to the
IL-17 response also suggests fascinating evolutionary
commonalties between the immune response to metazo-
an parasites and to other chitin containing pathogens such
as fungi that are highly dependent on IL-17 for control.
As with N. brasiliensis infection, neutrophils and macro-
phages act together to limit fungal growth and early IL-1
receptor signalling is central to this process [84]. Because
CLPs are upregulated in the context of both helminth
and fungal infection [85,86], their study may provide
answers to the causes of many pathologies involvingwww.sciencedirect.com dysregulated type 2 immunity as well as provide oppor-
tunities for intervention  in severe type 2 pathology.
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